Illumigyn incorporates existing machine vision technologies into a compact imaging colposcope for medical applications.
Illumigyn incorporates existing machine vision technologies into a compact imaging colposcope for medical applications in an effort to eliminate the inherent subjectivity of cervical exams. Its Gynescope is a patented imaging colposcope that delivers 15-micron image resolution over a wide field of view and a range of working distances. The Gynescope also has multispectral illumination options, allowing early detection of cervical cancer while meaningfully reducing misdiagnoses. The Gynescope enables sophisticated imaging with simultaneous complex interventional procedures to support the best clinical outcomes.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 3, 2021 | Series Unknown | $33M | 2 |
Ubicom Holdings
Yozma Group |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Ubicom Holdings | Yes | Series Unknown |
Yozma Group | Yes | Series Unknown |